Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
In your 20s, it's crucial to know what financial mistakes to avoid. Discover key insights to help you manage your money wisely.
26,712 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A potential hawkish shift in monetary policy could derail the AI stock surge, threatening lofty earnings multiples fo...
In the race to dominate AI-powered cloud services, Iren's ability rapidly scale data centers sets it apart. This arti...
EEM’s 0.69% fee quietly drags down returns for investors, especially over decades. A cheaper alternative, IEMG at 0.0...
Florida’s housing boom faces a growing threat: AI-enabled deed and title fraud. This report outlines the risks and pr...
Retirees face roughly $36,000 per year in aging-in-place costs, rising faster than Social Security. A carefully craft...
A CFO's share sale coincides with bold guidance and a explosive stock rally. This look at what this butterfly network...
February brought a sharp drop for Atlassian as investors digested earnings signals and AI risk. This guide breaks dow...
Oracle reports an 84% jump in cloud IaaS revenue and a customer-friendly BYOC GPU program as DCLA argues the company ...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
In a bold move, Solv Protocol plans to dump its LayerZero-backed tokenized Bitcoin tech and migrate to Chainlink. Thi...
A clear, investor-friendly look at HireQuest's Q1 2026 performance and what the numbers signal for HQI's earnings tra...